AAAAAA

   
Results: 1-19 |
Results: 19
SANFORD,JAY,P. - 1928-1996 - IN-MEMORIAM
Authors: SANDE MA GILBERT DN
Citation: Ma. Sande et Dn. Gilbert, SANFORD,JAY,P. - 1928-1996 - IN-MEMORIAM, Proceedings of the Association of American Physicians, 110(3), 1998, pp. 283-284
INFLUENCE OF ASSAY METHODOLOGY ON THE MEASUREMENT OF FREE SERUM CEFTRIAXONE CONCENTRATIONS
Authors: KOHLHEPP S GILBERT DN LEGGETT JE
Citation: S. Kohlhepp et al., INFLUENCE OF ASSAY METHODOLOGY ON THE MEASUREMENT OF FREE SERUM CEFTRIAXONE CONCENTRATIONS, Antimicrobial agents and chemotherapy, 42(9), 1998, pp. 2259-2261
A RANDOMIZED COMPARISON OF THE SAFETY AND EFFICACY OF ONCE-DAILY GENTAMICIN OR THRICE-DAILY GENTAMICIN IN COMBINATION WITH TICARCILLIN-CLAVULANATE
Authors: GILBERT DN LEE BL DWORKIN RJ LEGGETT JL CHAMBERS HF MODIN G TAUBER MG SANDE MA
Citation: Dn. Gilbert et al., A RANDOMIZED COMPARISON OF THE SAFETY AND EFFICACY OF ONCE-DAILY GENTAMICIN OR THRICE-DAILY GENTAMICIN IN COMBINATION WITH TICARCILLIN-CLAVULANATE, The American journal of medicine, 105(3), 1998, pp. 182-191
EDITORIAL RESPONSE - METAANALYSES ARE NO LONGER REQUIRED FOR DETERMINING THE EFFICACY OF SINGLE DAILY DOSING OF AMINOGLYCOSIDES
Authors: GILBERT DN
Citation: Dn. Gilbert, EDITORIAL RESPONSE - METAANALYSES ARE NO LONGER REQUIRED FOR DETERMINING THE EFFICACY OF SINGLE DAILY DOSING OF AMINOGLYCOSIDES, Clinical infectious diseases, 24(5), 1997, pp. 816-819
SANFORD,JAY,P. (1928-1996) - TRIBUTE
Authors: GILBERT DN
Citation: Dn. Gilbert, SANFORD,JAY,P. (1928-1996) - TRIBUTE, Clinical infectious diseases, 24(2), 1997, pp. 2-3
OUTPATIENT PARENTERAL ANTIMICROBIAL-DRUG THERAPY
Authors: GILBERT DN DWORKIN RJ RABER SR LEGGETT JE
Citation: Dn. Gilbert et al., OUTPATIENT PARENTERAL ANTIMICROBIAL-DRUG THERAPY, The New England journal of medicine, 337(12), 1997, pp. 829-838
SANFORD,JAY,P., MD - TRIBUTE
Authors: GILBERT DN
Citation: Dn. Gilbert, SANFORD,JAY,P., MD - TRIBUTE, The Journal of infectious diseases, 175(2), 1997, pp. 4-5
MYCOBACTERIUM-GORDONAE IN FIBEROPTIC BRONCHOSCOPES
Authors: JACKSON J LEGGETT JE WILSON D GILBERT DN
Citation: J. Jackson et al., MYCOBACTERIUM-GORDONAE IN FIBEROPTIC BRONCHOSCOPES, American journal of infection control, 24(1), 1996, pp. 19-23
ASPECTS OF THE SAFETY PROFILE OF ORAL ANTIBACTERIAL AGENTS
Authors: GILBERT DN
Citation: Dn. Gilbert, ASPECTS OF THE SAFETY PROFILE OF ORAL ANTIBACTERIAL AGENTS, Infectious diseases in clinical practice, 4, 1995, pp. 103-112
STAPHYLOCOCCUS-AUREUS SEPTIC ARTHRITIS IN PATIENTS ON HEMODIALYSIS-TREATMENT
Authors: SLAUGHTER S DWORKIN RJ GILBERT DN LEGGETT JE JONES S BRYANT R MARTIN MA
Citation: S. Slaughter et al., STAPHYLOCOCCUS-AUREUS SEPTIC ARTHRITIS IN PATIENTS ON HEMODIALYSIS-TREATMENT, Western journal of medicine, 163(2), 1995, pp. 128-132
PATIENTS WITH HUMAN-IMMUNODEFICIENCY-VIRUS INFECTION IN THE HEMODIALYSIS UNIT - HOW VULNERABLE ARE THE CAREGIVERS
Authors: GILBERT DN BENNETT W
Citation: Dn. Gilbert et W. Bennett, PATIENTS WITH HUMAN-IMMUNODEFICIENCY-VIRUS INFECTION IN THE HEMODIALYSIS UNIT - HOW VULNERABLE ARE THE CAREGIVERS, Archives of internal medicine, 155(15), 1995, pp. 1575-1576
BEAM,THOMAS,ROGER, JR, MD - 12-JULY-1946 TO 17-AUGUST-1994 - IN-MEMORIAM
Authors: MEYER RD GOLDSTEIN EJC KUNIN CM GILBERT DN
Citation: Rd. Meyer et al., BEAM,THOMAS,ROGER, JR, MD - 12-JULY-1946 TO 17-AUGUST-1994 - IN-MEMORIAM, Clinical infectious diseases, 19(6), 1994, pp. 1183-1183
INFECTIOUS-DISEASES-SOCIETY-OF-AMERICA AND HEALTH-CARE REFORM
Authors: GILBERT DN LAWTON SE LOEB L GOLDSTEIN EJC SANFORD JP MANDELL GL SANDE MA
Citation: Dn. Gilbert et al., INFECTIOUS-DISEASES-SOCIETY-OF-AMERICA AND HEALTH-CARE REFORM, Clinical infectious diseases, 19(2), 1994, pp. 372-375
ASPECTS OF THE SAFETY PROFILE OF ORAL ANTIBACTERIAL AGENTS
Authors: GILBERT DN
Citation: Dn. Gilbert, ASPECTS OF THE SAFETY PROFILE OF ORAL ANTIBACTERIAL AGENTS, Infectious diseases in clinical practice, 3(4), 1994, pp. 236-246
PIG-KIDNEY (LLC-PK1) CELL-MEMBRANE FLUIDITY DURING EXPOSURE TO GENTAMICIN OR TOBRAMYCIN
Authors: KOHLHEPP SJ HOU L GILBERT DN
Citation: Sj. Kohlhepp et al., PIG-KIDNEY (LLC-PK1) CELL-MEMBRANE FLUIDITY DURING EXPOSURE TO GENTAMICIN OR TOBRAMYCIN, Antimicrobial agents and chemotherapy, 38(9), 1994, pp. 2169-2171
AMINOGLYCOSIDE-INDUCED INCREASE OF INTRACELLULAR CALCIUM IN LLC-PK1 CELLS DUE TO AN ARTIFACT CAUSED BY TRYPSIN AND EDTA
Authors: KOHLHEPP SJ HERMSMEYER K LAND RA GILBERT DN
Citation: Sj. Kohlhepp et al., AMINOGLYCOSIDE-INDUCED INCREASE OF INTRACELLULAR CALCIUM IN LLC-PK1 CELLS DUE TO AN ARTIFACT CAUSED BY TRYPSIN AND EDTA, Antimicrobial agents and chemotherapy, 38(5), 1994, pp. 1065-1070
EUROPEAN GUIDELINES FOR ANTIINFECTIVE DRUG PRODUCTS - INTRODUCTION
Authors: BEAM TR GILBERT DN KUNIN CM
Citation: Tr. Beam et al., EUROPEAN GUIDELINES FOR ANTIINFECTIVE DRUG PRODUCTS - INTRODUCTION, Clinical infectious diseases, 17(4), 1993, pp. 787-788
EVALUATION OF NEW ANTIINFECTIVE DRUGS FOR THE TREATMENT OF VASCULAR ACCESS DEVICE ASSOCIATED BACTEREMIA AND FUNGEMIA
Authors: FRANSON TR ZAK O VANDENBROEK P BAQUERO F CARBON C CHRIST W FINCH RG JOHNSON A MEUNIER F NICOLIS F NORRBY SR REGNIER B SCHACHT P KINNING M BEAM TR GILBERT DN HIROTSU C KAWAHARA A MORIGA M SUNAKAWA K TSUKANO M YAGISAWA M
Citation: Tr. Franson et al., EVALUATION OF NEW ANTIINFECTIVE DRUGS FOR THE TREATMENT OF VASCULAR ACCESS DEVICE ASSOCIATED BACTEREMIA AND FUNGEMIA, Clinical infectious diseases, 17(4), 1993, pp. 789-793
EVALUATION OF NEW ANTIINFECTIVE DRUGS FOR THE TREATMENT OF INFECTION WITH HUMAN-IMMUNODEFICIENCY-VIRUS
Authors: NORRBY SR WHITLEY RJ BAQUERO F CARBON C CHRIST W FINCH RG JOHNSON A MEUNIER F NICOLIS F REGNIER B SCHACHT P VANDENBROEK P ZAK O KINNING M FRANSON T BEAM TR GILBERT DN HIROTSU C KAWAHARA A MORIGA M SUNAKAWA K TSUKANO M YAGISAWA M
Citation: Sr. Norrby et al., EVALUATION OF NEW ANTIINFECTIVE DRUGS FOR THE TREATMENT OF INFECTION WITH HUMAN-IMMUNODEFICIENCY-VIRUS, Clinical infectious diseases, 17(4), 1993, pp. 794-801
Risultati: 1-19 |